EANM Focus Meeting 3
The third edition of the EANM Focus Meeting comprises 5 tracks, aiming for a consensus statement, based on the tangible results of the multidisciplinary discussions.
|Track 1||Imaging of NET|
|Track 2||Imaging and Therapy of Pheochromocytoma and Paraganglioma|
|Track 3||PRRT of NET|
|Track 4||Treatment Monitoring|
|Track 5||Look into the Future|
The aim of the meeting is to provide an in-depth overview and critical assessment of the latest development and future directions in the management of neuroendocrine tumours, with a focus on the role of neuroimaging in general and nuclear medicine in particular. The goal is to arrive at a multidisciplinary consensus on the current state of the art and to make expert recommendations on how to advance the field towards establishing clinical impact.
|Early Registration Fee (until October 25, 2019)||EUR 650.00|
|Late Registration Fee (from October 26, 2019)||EUR 850.00|
You are cordially invited to attend the third EANM Focus Meeting in the Wyndham Grand Hotel in Athens, Greece, on January 30–February 1, 2020. Registrations are limited to 250 participants and will be allocated on a first-come, first-served basis, so please reserve your attendance as soon as possible.
Hotel Wyndham Grand Athens
2 Megalou Alexandrou
104 37, Athens
For any further information have a look at the Focus Meeting website.
We hope to welcome you to the beautiful city of Athens in early 2020 for the third edition of this exciting new EANM initiative.